$赛托瑞疗法(CYTX)$ CORRESP [Cover] - Correspondence Filed: 2017-11-01 AccNo: 0001564590-17-020860 Size: 10 KB 网页链接
$赛托瑞疗法(CYTX)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2017-11-28 AccNo: 0001564590-17-024305 Size: 51 KB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-11-28 AccNo: 0001564590-17-024297 Size: 182 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01...
$赛托瑞疗法(CYTX)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2017-11-14 AccNo: 0001564590-17-023837 Size: 104 KB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001564590-17-023529 Size: 34 KBItem 8.01: Other Events 网页链接
$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-09 AccNo: 0001564590-17-023317 Size: 3 MB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-11-09 AccNo: 0001564590-17-023286 Size: 635 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 美东时间 2017-11-09 盘后 披露财报,预期EPS -0.09 网页链接
$赛托瑞疗法(CYTX)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2017-11-03 AccNo: 0001564590-17-021333 Size: 712 KB 网页链接
$赛托瑞疗法(CYTX)$ EFFECT - Notice of Effectiveness Filed: 2017-11-02 AccNo: 9999999995-17-002846 Size: 1 KB 网页链接